These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1994734)

  • 1. The clinical spectrum of thrombocytosis and thrombocythemia.
    Frenkel EP
    Am J Med Sci; 1991 Jan; 301(1):69-80. PubMed ID: 1994734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia.
    Wadenvik H; Kutti J; Ridell B; Revesz P; Jacobsson S; Magnusson B; Westin J; Vilén L
    Blood; 1991 May; 77(10):2103-8. PubMed ID: 2029575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term management of thrombocytosis in essential thrombocythaemia.
    Birgegård G
    Ann Hematol; 2009 Jan; 88(1):1-10. PubMed ID: 18629498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features].
    Marta RF; Goette NP; Molinas FC
    Medicina (B Aires); 2006; 66(6):540-6. PubMed ID: 17240625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential thrombocythemia.
    Schafer AI
    Prog Hemost Thromb; 1991; 10():69-96. PubMed ID: 2008534
    [No Abstract]   [Full Text] [Related]  

  • 6. [A preschool child with primary thrombocytosis].
    Ling C; Zhu GH; Jin L
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):541-2. PubMed ID: 24267139
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombocytosis: too much of a good thing?
    Schafer AI
    Trans Am Clin Climatol Assoc; 2002; 113():68-76; discussion 76-7. PubMed ID: 12053719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review of anagrelide therapy in essential thrombocythemia and related disorders.
    Dingli D; Tefferi A
    Leuk Lymphoma; 2005 May; 46(5):641-50. PubMed ID: 16019501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-6 levels in patients with thrombocytosis.
    Hollen CW; Henthorn J; Koziol JA; Burstein SA
    Leuk Lymphoma; 1992 Oct; 8(3):235-41. PubMed ID: 1490150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytosis.
    Schafer AI
    N Engl J Med; 2004 Mar; 350(12):1211-9. PubMed ID: 15028825
    [No Abstract]   [Full Text] [Related]  

  • 11. Anagrelide: a new drug for treating thrombocytosis.
    Silverstein MN; Petitt RM; Solberg LA; Fleming JS; Knight RC; Schacter LP
    N Engl J Med; 1988 May; 318(20):1292-4. PubMed ID: 3362187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders.
    Balduini CL; Bertolino G; Noris P; Ascari E
    Haematologica; 1992; 77(1):40-3. PubMed ID: 1398280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary thrombocytosis in childhood.
    Dame C; Sutor AH
    Br J Haematol; 2005 Apr; 129(2):165-77. PubMed ID: 15813844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
    Iványi JL; Marton É; Plander M; Szendrei T
    Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for lowering platelet numbers in essential thrombocythemia.
    Barbui T
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):22-5. PubMed ID: 12682878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
    Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H
    Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary thrombocythemia: a current perspective.
    Mughal TI
    Stem Cells; 1995 Jul; 13(4):355-9. PubMed ID: 7549894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary and primary thrombocythemia].
    Judkiewicz L
    Acta Haematol Pol; 1993; 24(2 Suppl 1):15-20. PubMed ID: 8362612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet characteristics in patients with essential thrombocytosis.
    Pedersen OH; Larsen ML; Grove EL; van Kooten Niekerk PB; Bønløkke S; Nissen PH; Kristensen SD; Hvas AM
    Cytometry B Clin Cytom; 2018 Nov; 94(6):918-927. PubMed ID: 29790256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia.
    Laguna MS; Kornblihtt LI; Marta RF; Michiels JJ; Molinas FC
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):157-61. PubMed ID: 10898276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.